Sionna Therapeutics, Inc. (SION)

NASDAQ: SION · Real-Time Price · USD

6.06

-0.11 (-1.78%)

At close: Aug 27, 2026, 4:00 PM EDT

6.03

-0.03 (-0.50%)

After-hours: Aug 27, 2026, 7:48 PM EDT

Sionna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	63.32	58.45	37.79	38.52	54.84
Short-Term Investments	147.71	177.43	109.75	-	27.77
Cash & Short-Term Investments	211.03	235.88	147.54	38.52	82.61
Cash Growth	-19.63%	59.88%	283.01%	-53.37%	-
Prepaid Expenses	5.1	5.54	3.46	0.69	1.22
Total Current Assets	216.13	241.42	150.99	39.21	83.83
Property, Plant & Equipment	8.34	9.15	10.3	11.62	1.79
Long-Term Investments	57.22	74.42	20.51	-	-
Other Long-Term Assets	1.56	0.96	3.96	1.12	1.74
Total Assets	283.25	325.95	185.75	51.95	87.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	0.52	0.77	1.19	0.72	0.56
Accrued Expenses	8.88	9.67	7.67	6.59	7.7
Current Portion of Leases	1.38	1.27	1.07	0.73	-
Other Current Liabilities	0.01	0.01	0.49	-	-
Total Current Liabilities	10.78	11.71	10.42	8.04	8.25
Long-Term Leases	6.69	7.41	8.68	9.75	-
Total Liabilities	17.47	19.12	19.1	17.79	8.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.05	0.05	0.01	0	0
Additional Paid-In Capital	579.2	562.6	17	4.52	2.23
Retained Earnings	-313.02	-256.35	-181.09	-119.4	-72.14
Comprehensive Income & Other	-0.45	0.54	0.37	-	-0.02
Total Common Equity	265.78	306.83	-163.71	-114.88	-69.92
Shareholders' Equity	265.78	306.83	166.66	34.16	79.12
Total Liabilities & Equity	283.25	325.95	185.75	51.95	87.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	8.07	8.68	9.75	10.48	-
Net Cash (Debt)	260.18	301.63	158.29	28.04	82.61
Net Cash Growth	-20.68%	90.55%	464.45%	-66.05%	-
Net Cash Per Share	5.79	7.55	41.02	9.56	32.05
Filing Date Shares Outstanding	45.21	45	44.12	3.05	2.58
Total Common Shares Outstanding	45.16	44.72	4.72	3.05	2.58
Working Capital	205.35	229.71	140.57	31.17	75.58
Book Value Per Share	5.88	6.86	-34.66	-37.66	-27.13
Tangible Book Value	265.78	306.83	-163.71	-114.88	-69.92
Tangible Book Value Per Share	5.88	6.86	-34.66	-37.66	-27.13
Machinery	2.43	2.43	2.18	2.05	0.62
Construction In Progress	-	-	-	-	1.52
Leasehold Improvements	1.92	1.92	1.85	1.85	-

SEC Filings: 10-K · 10-Q